GlaxoSmithKline, Research Triangle Park, NC, USA.
Biotechniques. 2012 Apr;52(4):273-5. doi: 10.2144/000113841.
The use of subgenomic replicon systems has long been a valuable screening tool for the discovery of small molecule antivirals against Hepatitis C virus. While genotype 1a replicon systems have been widely used in stable systems, use in transient assays has been hampered by low signal. Here we describe the generation of a more robust genotype 1a (H77) replicon through the introduction of two fitness mutations, NS4A-K1691R and NS4B-E1726G, for use in transient transfections. While these mutations significantly improved the signal to noise ratio, leading to more robust data, they have no effect on the potency of tool compounds against various targets of HCV, thereby making this new system a powerful tool for screening of compounds against the genotype 1a replicon.
亚基因组复制子系统的应用长期以来一直是发现抗丙型肝炎病毒小分子抗病毒药物的有价值的筛选工具。虽然 1a 基因型复制子系统已广泛用于稳定系统,但由于信号低,在瞬时测定中使用受到阻碍。在这里,我们描述了通过引入两个适应性突变 NS4A-K1691R 和 NS4B-E1726G 来生成更稳健的 1a(H77)复制子,用于瞬时转染。虽然这些突变显著提高了信噪比,从而获得更稳健的数据,但它们对工具化合物针对 HCV 各种靶标的效力没有影响,从而使这个新系统成为筛选针对 1a 基因型复制子的化合物的有力工具。